Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Jonuleit

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Experimental Dermatology|February 9, 2007
Oxymetazoline modulates proinflammatory cytokines and the T-cell stimulatory capacity of dendritic cellsAndrea Tuettenberg, Stephan Koelsch, Jürgen Knop, et al.
Cells|September 26, 2025
Impaired PTEN Expression in T Cells Drives Resistance to Treg-Mediated Immune Regulation in Multiple SclerosisJanine Schlöder, Bettina Trinschek, Felix Luessi, et al.
Frontiers in Immunology|November 24, 2017
Novel Concept of CD4-Mediated Activation of Regulatory T Cells for the Treatment of Graft-Versus-Host DiseaseJanine Schlöder, Carsten Berges, Andrea Tuettenberg, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 7, 2007
Dendritic cell-based immunotherapy of malignant melanoma: success and limitationsAndrea Tuettenberg, Edgar Schmitt, Jürgen Knop, et al.
Experimental Dermatology|May 27, 2010
Increased regulatory T-cell frequencies in patients with advanced melanoma correlate with a generally impaired T-cell responsiveness and are restored after dendritic cell-based vaccinationAnita Correll, Andrea Tuettenberg, Christian Becker, et al.
Clinical Laboratory|March 12, 2011
Immune regulation by dendritic cells and T cells--basic science, diagnostic, and clinical applicationAndrea Tuettenberg, Christian Becker, Anita Correll, et al.
Chemmedchem|July 5, 2017
Immunization with a Synthetic Human MUC1 Glycopeptide Vaccine against Tumor-Associated MUC1 Breaks Tolerance in Human MUC1 Transgenic MiceNatascha Stergiou, Markus Glaffig, Helmut Jonuleit, et al.
European Journal of Immunology|April 5, 2007
CD4-mediated functional activation of human CD4+CD25+ regulatory T cellsChristian Becker, Jan Kubach, John Wijdenes, et al.
Medical Microbiology and Immunology|May 23, 2006
Regulatory T cells: present facts and future hopesChristian Becker, Sabine Stoll, Tobias Bopp, et al.
International Journal of Cancer|June 21, 2014
IgG1 anti-epidermal growth factor receptor antibodies induce CD8-dependent antitumor activityJan Kubach, Mario Hubo, Christiane Amendt, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Experimental Dermatology|February 9, 2007
Oxymetazoline modulates proinflammatory cytokines and the T-cell stimulatory capacity of dendritic cellsAndrea Tuettenberg, Stephan Koelsch, Jürgen Knop, et al.
Cells|September 26, 2025
Impaired PTEN Expression in T Cells Drives Resistance to Treg-Mediated Immune Regulation in Multiple SclerosisJanine Schlöder, Bettina Trinschek, Felix Luessi, et al.
Frontiers in Immunology|November 24, 2017
Novel Concept of CD4-Mediated Activation of Regulatory T Cells for the Treatment of Graft-Versus-Host DiseaseJanine Schlöder, Carsten Berges, Andrea Tuettenberg, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 7, 2007
Dendritic cell-based immunotherapy of malignant melanoma: success and limitationsAndrea Tuettenberg, Edgar Schmitt, Jürgen Knop, et al.
Experimental Dermatology|May 27, 2010
Increased regulatory T-cell frequencies in patients with advanced melanoma correlate with a generally impaired T-cell responsiveness and are restored after dendritic cell-based vaccinationAnita Correll, Andrea Tuettenberg, Christian Becker, et al.
Clinical Laboratory|March 12, 2011
Immune regulation by dendritic cells and T cells--basic science, diagnostic, and clinical applicationAndrea Tuettenberg, Christian Becker, Anita Correll, et al.
Chemmedchem|July 5, 2017
Immunization with a Synthetic Human MUC1 Glycopeptide Vaccine against Tumor-Associated MUC1 Breaks Tolerance in Human MUC1 Transgenic MiceNatascha Stergiou, Markus Glaffig, Helmut Jonuleit, et al.
European Journal of Immunology|April 5, 2007
CD4-mediated functional activation of human CD4+CD25+ regulatory T cellsChristian Becker, Jan Kubach, John Wijdenes, et al.
Medical Microbiology and Immunology|May 23, 2006
Regulatory T cells: present facts and future hopesChristian Becker, Sabine Stoll, Tobias Bopp, et al.
International Journal of Cancer|June 21, 2014
IgG1 anti-epidermal growth factor receptor antibodies induce CD8-dependent antitumor activityJan Kubach, Mario Hubo, Christiane Amendt, et al.
Pageof 7